Zogenix
ExitedZogenix engages in the development and commercialization of products for the treatment of central nervous system disorders and pain.
Zogenix is tracked in the Tech.eu funding database. Based in San Diego, United States; active in Healthtech. Acquired by UCB in 2022. Data as of Nov 2026.
San Diego, United Stateszogenix.com ↗
Total raised
—
no tracked rounds
Funding rounds
0
Investors
0
distinct backers
Active since
—
Funding rounds
0 roundsNo funding rounds recorded.
Exit
Type
acquisition
Date
Jan 2022
Value
€1.7B
Acquiror
UCB (Belgium)
Related news
- Brusselse farmareus koopt Amerikaanse sectorgenoot voor 1,7 miljard eurobloovi.be · 2022-01
Similar companies
same sector, similar size- Sencilia—Netherlands · Healthtech
- Clinithink—UK · Healthtech
- Care—Switzerland · Healthtech
- TimeTeller—Germany · Healthtech
- NeoPrediX—Germany · Healthtech
- Chiron Health AI—UK · Healthtech
Global coverage: FundingData